Form 4 holding
EVP & Chief Medical Officer
Deciphera Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 11 Jun 2024
- Price
- $15.62
- Ownership
- Direct
Matthew L. Sherman - EVP & Chief Medical Officer at Deciphera Pharmaceuticals, Inc.
Issuer-level insider activity
- Role
- EVP & Chief Medical Officer
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Matthew L. Sherman since 01 Aug 2025
Reported holdings for Matthew L. Sherman in Deciphera Pharmaceuticals, Inc.
Form 4 holding
EVP & Chief Medical Officer
Deciphera Pharmaceuticals, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 11 Jun 2024
- Price
- $10.58
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Matthew L. Sherman in Deciphera Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.